Skip to main content
NCBI home page
Cytotechnology logoLink to Cytotechnology
. 2003 Nov;43(1-3):81–88. doi: 10.1023/B:CYTO.0000039895.11048.1b

Interleukin 12 and CD86 Regulate Th1 and Th2 Development Induced by a Range of Antigen Doses Presented by Peyer's Patch and Spleen Cells

Tadashi Yoshida 1, Satoshi Hachimura 1, Mina Ishimori 1, Wataru Ise 1, Mamoru Totsuka 1, Akio Ametani 2, Shuichi Kaminogawa 1
PMCID: PMC3449607  PMID: 19003211

Abstract

In this study, we demonstrate the role of interleukin 12 (IL-12), CD80 and CD86 in T helper type 1 (Th1) and Th2 differentiation induced through antigen presentation by Peyer's patch (PP) and spleen (SPL) cells with various doses of antigen. IL-12 was found to be critical for the induction of Th1-type cytokine producing cells, while antigen-dose dependent patterns of differentiation into Th2-type cytokine producing cells were not altered by the blockade of IL-12. Further, the difference in the pattern of Th2-type cytokine producing cell differentiation induced by PP and SPL cells depending on the antigen dosage were preserved in the absence of IL-12. When the function of CD86 was blocked by specific antibody, the induction of Th1-type cytokine producing cells was kept at high levels through every antigen dose, and the difference between PP and SPL cells was abrogated. With regard to Th2 induction, CD86 enhanced the differentiation of Th2-type cytokine producing cells but it was not essential in the case of antigen presentation by SPL cells. These results suggest that antigen-dose dependent changes in Th2 cell induction are regulated by additional factors which cannot induce antigen-dose dependent changes in Th1 cell differentiation by themselves.

Keywords: antigen presentation, CD86, IL-12, Peyer's patch, Th1/Th2

Full Text

The Full Text of this article is available as a PDF (119.5 KB).

References

  1. Boutin Y., Leitenberg D., Tao X., Bottomly K. Distinct biochemical signals characterize agonist-and altered peptide ligand-induced differentiation of naive CD4+ T cells into Th1 and Th2 subsets. J.Immunol. 1997;159:5802–5809. [PubMed] [Google Scholar]
  2. Constant S., Pfeiffer C., Pasqualini T., Bottomly K. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J.Exp.Med. 1995;182:1591–1596. doi: 10.1084/jem.182.5.1591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Freeman G.J., Boussiotis V.A., Anumanthan A., Bernstein G.M., Ke X.Y., Rennert P.D., Gray G.S., Gribben J., Nadler L.M. B7-1 and B7-2 do not deliver identical costimulatory signals,since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity. 1995;2:523–532. doi: 10.1016/1074-7613(95)90032-2. [DOI] [PubMed] [Google Scholar]
  4. Friedman A., Weiner H.L. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc.Natl.Acad.Sci. 1994;91:6688–6692. doi: 10.1073/pnas.91.14.6688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. George A., Cebra J.J. Responses of single germinal-center B cells in T-cell-dependent microculture. Proc.Natl. Acad.Sci. 1991;88:11–15. doi: 10.1073/pnas.88.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hosken N.A., Shibuya K., Heath A.W., Murphy K.M., O'Garra A.O. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-ab transgenic model. J.Exp.Med. 1995;182:1579–1584. doi: 10.1084/jem.182.5.1579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ise W., Totsuka M., Takato R., Hachimura S., Sato T., Ame-tani A., Kumagai Y., Habu S., Kaminogawa S. Primary response of naive CD4+ T cells to amino acid-substituted analogs of an antigenic peptide can show distinct activation patterns: Th1-and Th2-type cytokine secretion, and helper activity for antibody production without apparent cytokine secretion. FEBS Lett. 2000;465:28–33. doi: 10.1016/S0014-5793(99)01716-0. [DOI] [PubMed] [Google Scholar]
  8. Ise W., Totsuka M., Sogawa Y., Ametani A., Hachimura S., Sato T., Kumagai Y., Habu S., Kaminogawa S. Naive CD4+ T cells exhibit distinct expression patterns of cytokines and cell surface molecules on their primary re-sponses to varying doses of antigen. J.Immunol. 2002;168:3242–3250. doi: 10.4049/jimmunol.168.7.3242. [DOI] [PubMed] [Google Scholar]
  9. Iwasaki A., Kelsall B.L. Freshly isolated Peyer 's patch,but not spleen,dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J.Exp. Med. 1999;190:229–239. doi: 10.1084/jem.190.2.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Iwasaki A., Kelsall B.L. Localization of distinct Pe-yer 's patch dendritic cell subsets and their recruitment by chemokines macrophage in.ammatory protein (MIP)-3 a MIP-3 b and secondary lymphoid organ chemokine. J.Exp.Med. 2000;191:1381–1394. doi: 10.1084/jem.191.8.1381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Iwasaki A., Kelsall B.L. Unique functions of CD11b+ ,CD8 α+ ,and double-negative Peyer 's patch dendritic cells. J.Immunol. 2001;166:4884–4890. doi: 10.4049/jimmunol.166.8.4884. [DOI] [PubMed] [Google Scholar]
  12. Moser M. Regulation of Th1/Th2 development by anti-gen-presenting cells in vivo. Immunobiol. 2001;204:551–557. doi: 10.1078/0171-2985-00092. [DOI] [PubMed] [Google Scholar]
  13. Nuriya S., Yagita H., Okumura K., Azuma M. The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hyper-sensitivity. Int.Immunol. 1996;8:917–926. doi: 10.1093/intimm/8.6.917. [DOI] [PubMed] [Google Scholar]
  14. Ranger A.M., Das M.P., Kuchroo V., Glimcher L.H. B7-2 (CD86)is essential for the development of IL-4-producing T cells. Int.Immunol. 1996;8:1549–1560. doi: 10.1093/intimm/8.10.1549. [DOI] [PubMed] [Google Scholar]
  15. Rogers P., Croft M. CD28,Ox-40,LFA-1,and CD4 modulation of Th1/Th2 differentiation is directly dependent on the dose of antigen. J.Immunol. 2000;164:2955–2963. doi: 10.4049/jimmunol.164.6.2955. [DOI] [PubMed] [Google Scholar]
  16. Ruedl C., Bachmann M., Kopf M. The antigen dose determines T helper subset development by regulation of CD40 ligand. Eur.J.Immunol. 2000;30:2056–2064. doi: 10.1002/1521-4141(200007)30:7<2056::AID-IMMU2056>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
  17. Sato T., Sasahara T., Nakamura Y., Osaki T., Hasegawa T., Tadakura T., Arata Y., Kumagai Y., Katsuki M., Habu S. Naive T cells can mediate delayed-type hypersensi-tivity response in T cell receptor transgenic mice. Eur.J. Immunol. 1994;24:1512–1516. doi: 10.1002/eji.1830240708. [DOI] [PubMed] [Google Scholar]
  18. Spalding D.M., Williamson S.I., Koopman W., McGhee J.R. Preferential induction of polyclonal IgA secretion by murine Peyer 's patch dendritic cell-T cell mixtures. J.Exp. Med. 1984;160:941–946. doi: 10.1084/jem.160.3.941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tsuji N.M., Mizumachi K., Kurisaki J. IL-10 secreting Peyer 's patch cells are responsible for active suppression in low-dose oral tolerance. Immunology. 2001;103:458–464. doi: 10.1046/j.1365-2567.2001.01265.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Yoshida T., Hachimura S., Kaminogawa S. The oral administration of low-dose antigen induces activation followed by tolerization,while high-dose antigen induces tolerance without activation. Clin.Immunol.Immunopathol. 1997;82:207–215. doi: 10.1006/clin.1996.4319. [DOI] [PubMed] [Google Scholar]
  21. Yoshida T., Hachimura S., Ishimori M., Kinugasa F., Ise W., Totsuka M., Ametani A., Kaminogawa S. Antigen presentation by Peyer 's patch cells can induce both Th1-and Th2-type responses depending on antigen dosage,but a dif-ferent cytokine response pattern from that of spleen cells. Biosci.Biotechnol.Biochem. 2002;66:963–969. doi: 10.1271/bbb.66.963. [DOI] [PubMed] [Google Scholar]

Articles from Cytotechnology are provided here courtesy of Springer Science+Business Media B.V.

RESOURCES